Italia markets close in 1 minute

BMY Aug 2024 50.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5800+0,0200 (+3,57%)
In data: 10:38AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,5600
Aperto0,5700
Denaro0,5600
Lettera0,5900
Prezzo d'esercizio50,00
Scadenza2024-08-16
Min-Max giorno0,5700 - 0,5800
Contratto - Min-MaxN/D
Volume23
Open Interest3,83k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri